Literature DB >> 6025489

Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries.

C W Bardin, M B Lipsett.   

Abstract

The average plasma testosterone concentration of women with either hirsutism or polycystic ovaries and hirsutism was higher (p < 0.01) than that of normal women although the ranges overlapped. Testosterone blood production rates averaged 830 +/- 120 SE and 1,180 +/- 310 SE mug per day in the two groups of hirsute women and 230 +/- 33 SE mug per day in normal women. The ranges did not overlap. The testosterone metabolic clearance rates of hirsute women (1,090 +/- 140 SE L per day) and of men (1,240 +/- 136 SE L per day) were significantly higher than those of normal women (590 +/- 44 SE L per day). These differences persisted when the metabolic clearance rates were corrected for surface area. We suggest that testosterone metabolic clearance rates vary directly with some function of testosterone production. The mean plasma androstenedione levels (2.8 +/- 0.35 SE and 2.8 +/- 0.30 SE mug per L) and production rates (6,060 +/- 450 SE and 7,360 +/- 345 SE mug per day) of the women with hirsutism or polycystic ovaries, respectively, were significantly higher than those of normal women (1.5 +/- 0.22 SE mug per L; 3,300 +/- 830 SE mug per day). The androstenedione metabolic clearance rates were the same in each group. Plasma androstenedione was the precursor of 49% of plasma testosterone in normal women and of 26% of plasma testosterone in hirsute women. Thus, 74% of the plasma testosterone in these subjects must have been either secreted or derived from a precursor that did not enter the plasma androstenedione pool.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6025489      PMCID: PMC297090          DOI: 10.1172/JCI105588

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  TESTOSTERONE PRODUCTION IN NORMAL AND VIRILIZED WOMEN AND IN WOMEN WITH THE STEIN-LEVENTHAL SYNDROME OR IDIOPATHIC HIRSUTISM.

Authors:  S G KORENMAN; M A KIRSCHNER; M B LIPSETT
Journal:  J Clin Endocrinol Metab       Date:  1965-06       Impact factor: 5.958

2.  DIRECT PERIPHERAL CONVERSION OF DEHYDROEPIANDROSTERONE TO TESTOSTERONE GLUCURONOSIDE.

Authors:  S G KORENMAN; M B LIPSETT
Journal:  Steroids       Date:  1965-04       Impact factor: 2.668

3.  Glucocorticoid suppression of urinary testosterone excretion in patients with idiopathic hirsutism.

Authors:  T Nichols; C A Nugent; F H Tyler
Journal:  J Clin Endocrinol Metab       Date:  1966-01       Impact factor: 5.958

4.  Plasma testosterone and urinary 17-ketosteroids in women with hirsutism and polycystic ovaries.

Authors:  C W Lloyd; J Lobotsky; E J Segre; T Kobayashi; M L Taymor; R E Batt
Journal:  J Clin Endocrinol Metab       Date:  1966-03       Impact factor: 5.958

Review 5.  Studies on Leydig cell physiology and pathology: secretion and metabolism of testosterone.

Authors:  M B Lipsett; H Wilson; M A Kirschner; S G Korenman; L M Fishman; G A Sarfaty; C W Bardin
Journal:  Recent Prog Horm Res       Date:  1966

6.  Steroid adsorption with polyethylene tubinh.g.

Authors:  J Levin; E H Friedrich; J Lobotsky
Journal:  J Clin Endocrinol Metab       Date:  1965-11       Impact factor: 5.958

7.  Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.

Authors:  R Horton; J F Tait
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

8.  Steroid-protein interaction with particular reference to testosterone binding by human serum.

Authors:  W H Pearlman; O Crépy
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

9.  Testosterone metabolism by human male mammary skin. I.

Authors:  E L Rongone
Journal:  Steroids       Date:  1966-06       Impact factor: 2.668

10.  Plasma production rates of testosterone in normal adult men and women and in patients with the syndrome of feminizing testes.

Authors:  A L Southren; S Tochimoto; N C Carmody; K Isurugi
Journal:  J Clin Endocrinol Metab       Date:  1965-11       Impact factor: 5.958

View more
  30 in total

1.  Hirsutism and anovulatory infertility.

Authors:  R V Brooks
Journal:  Postgrad Med J       Date:  1972-01       Impact factor: 2.401

2.  Skin collagen and thickness in women with hirsuties.

Authors:  S Shuster; M M Black; E Bottoms
Journal:  Br Med J       Date:  1970-12-26

3.  Sites of in vivo extraction and interconversion of testosterone and androstenedione in dogs.

Authors:  A Chapdelaine
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

4.  Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.

Authors:  R J Kurman
Journal:  West J Med       Date:  1979-12

5.  Low-dose transdermal testosterone augmentation therapy improves depression severity in women.

Authors:  Karen K Miller; Roy H Perlis; George I Papakostas; David Mischoulon; Dan V Losifescu; Danielle J Brick; Maurizio Fava
Journal:  CNS Spectr       Date:  2009-12       Impact factor: 3.790

6.  Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man.

Authors:  J D Veldhuis; A D Rogol; E Samojlik; N H Ertel
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

7.  The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-alpha-androstanediols.

Authors:  J A Mahoudeau; C W Bardin; M B Lipsett
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

8.  3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.

Authors:  R Horton; D Hawks; R Lobo
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

9.  Adrenal androgen abnormalities in women with late onset and persistent acne.

Authors:  H Aizawa; M Niimura
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

10.  Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms.

Authors:  R J Santen; C W Bardin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.